OCULOPHARYNGEAL MUSCULAR DYSTROPHY
Clinical trials for OCULOPHARYNGEAL MUSCULAR DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new OCULOPHARYNGEAL MUSCULAR DYSTROPHY trials appear
Sign up with your email to follow new studies for OCULOPHARYNGEAL MUSCULAR DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy injection aims to restore swallowing in rare muscle disorder
Disease control Recruiting nowThis study tests a single injection of BB-301 into throat muscles to improve swallowing in people with oculopharyngeal muscular dystrophy (OPMD). About 30 adults aged 50-65 who have already been in a natural history study will receive the treatment during a short surgery. The mai…
Matched conditions: OCULOPHARYNGEAL MUSCULAR DYSTROPHY
Phase: PHASE1, PHASE2 • Sponsor: Benitec Biopharma, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
Spit test may reveal clues about rare muscle disease
Knowledge-focused Recruiting nowThis study looks at whether people with Oculopharyngeal Muscular Dystrophy (OPMD) have thicker saliva and worse oral health compared to healthy individuals. Researchers will collect saliva samples and check mouth health in 100 participants, including patients and their household …
Matched conditions: OCULOPHARYNGEAL MUSCULAR DYSTROPHY
Sponsor: Sheba Medical Center • Aim: Knowledge-focused
Last updated May 17, 2026 10:41 UTC